Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04356573
Other study ID # 206814
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date November 20, 2018

Study information

Verified date October 2021
Source University of Arkansas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The specific hypothesis is that the consumption of 2 Hayward green kiwifruit (containing actinidin protease) prior to 100g of ground beef will increase the rate of protein digestion from the beef in the elderly, leading to an increased uptake of the essential amino acids. Furthermore, this increased essential amino acid availability will produce a greater postprandial net anabolic protein response, as well as increased fractional synthetic rates of muscle proteins.


Description:

The specific hypothesis is that the consumption of 2 Hayward green kiwifruit (containing actinidin protease) prior to 100g of ground beef will increase the rate of protein digestion from the beef in the elderly, leading to an increased uptake of the essential amino acids. Furthermore, this increased essential amino acid availability will produce a greater postprandial net anabolic protein response, as well as increased fractional synthetic rates of muscle proteins. To test this hypothesis, the investigators will use a double-blinded crossover design involving two intervention arms; in both arms 100g of ground beef (cooked weight) will be consumed following either 2 Hayward green kiwifruit (containing actinidin protease) or 2 Hort16A Gold kiwifruit (devoid of actinidin protease) by elderly subjects.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date November 20, 2018
Est. primary completion date November 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 85 Years
Eligibility Inclusion Criteria: - men and women ages 60-85 inclusive. Exclusion Criteria: - Inability to chew meats or difficulty swallowing solid foods - History of diabetes - History of malignancy in the 6 months prior to enrolment - History of gastrointestinal reduction or bypass surgery (Lapband, etc) - History of a chronic inflammatory condition or disease (Lupus, HIV'AIDS, etc) - History of chronic kidney disease or currently requiring dialysis. - Allergy to beef or kiwifruit - Subjects who do not or will not eat animal proteins - Subjects who cannot refrain from consuming protein or amino acid supplements during their participation in this study - Subjects who report regular resistance exercise (more than once per week) - Hemoglobin less than 9.5mg/dL at the screening visit - Platelets less than <150,000 at the screening visit - Subjects who are not willing or able to suspend aspirin for several days prior to their muscle biopsies. - Subjects who have been prescribed a blood-thinning medication (Coumadin, lovenox, heparin, Plavix, etc). - Concomitant use of corticosteroids (ingestion, injection or transdermal) - Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Green Hayward Kiwifruit first, then Gold Kiwifruit
Subjects ate 2 peeled green kiwifruit with their midday meal for 2 weeks prior to testing.
Gold Kiwifruit First, then Green Hayward Kiwifruit
Subjects ate 2 peeled gold kiwifruit with their midday meal for 2 weeks prior to testing.

Locations

Country Name City State
United States UAMS Center on Aging Little Rock Arkansas

Sponsors (1)

Lead Sponsor Collaborator
University of Arkansas

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Whole Body Net Balance Measured by Gas Chromatography-Mass Spectrometry (GC-MS) Blood samples were analyzed to quantify the appearance of the stable isotopes: 2H2-tyrosine, 2H4-tyrosine, and 2H5-phenylalanine in tracer to tracee ratio or mole percent excess. Changes in these markers over time enable the calculation of whole body protein metabolism. Calculations are done as follows:
Total plasma rate of appearance = infusion rate/enrichment Fractional rate of appearance of tyrosine from phenylalanine= 2H4-tyrosine/2H5-phenylalanine Phenylalanine hydroxylation = fractional rate of appearance of tyrosine from phenylalanine x rate of appearance of tyrosine Protein Synthesis = [(rate of appearance of phenylalanine -Phe hydroxylation) x 25] Protein Breakdown = [(rate of appearance of phenylalanine - phenylalanine infusion rate) x 25 - phenylalanine intake] Net Balance = Protein Synthesis - Protein Breakdown
300 minutes
Secondary Change in Skeletal Muscle Protein Metabolism Measured by Gas Chromatography-Mass Spectrometry (GC-MS) Muscle samples were analyzed to quantify the appearance of the stable isotope 2H5-phenylalanine in trace to tracee ratio or mole percent excess. The change in 2H5-phenylalanine in subsequent muscle biopsy allow for the calculation of muscle protein synthesis. The calculation is done as follows: [(2H5-phenylalanine enrichment in second biopsy - 2H5-phenylalanine enrichment in second biopsy)/ (2H5-phenylalanine plasma enrichment × time)] × 60 × 100. 9.5 hours
See also
  Status Clinical Trial Phase
Completed NCT00070577 - Influence of Age and Sex on Alcohol Metabolism and Acute Responses N/A
Active, not recruiting NCT05488574 - Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss N/A
Recruiting NCT05582824 - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting NCT05443347 - Activity, Adiposity, and Appetite in Adolescents 2 Intervention N/A
Completed NCT05020808 - The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise N/A
Recruiting NCT06082726 - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers N/A
Completed NCT04144426 - Meal Schedule Effects on Circadian Energy Balance in Adults N/A
Completed NCT03424395 - Personalized Dietary Program and Markers of Wellness N/A
Completed NCT02441296 - Carbohydrate and Metabolism: a Pilot Study N/A
Completed NCT00176085 - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH Phase 1
Completed NCT00245986 - Effect of Genetics on Metabolism of Efavirenz Phase 4
Completed NCT04025346 - To Evaluate the Efficacy of Capsimax on Metabolic Rate N/A
Completed NCT04078646 - Influence of Proteins on the Bioavailability of Carotenoids N/A
Active, not recruiting NCT06033898 - Inactivity Duration on Lipid Metabolism N/A
Active, not recruiting NCT06250270 - Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning Early Phase 1
Completed NCT06285578 - Effects of Probiotic and HIIT in Obese Women N/A
Completed NCT04255368 - Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response N/A
Recruiting NCT06360796 - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 Phase 1
Recruiting NCT02005003 - Cognitive and Metabolic Effects of a Probiotic Supplement N/A
Completed NCT03146728 - Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia N/A